EligibleTrials

Clinical trials recruiting for Recurrent Breast Cancer

4
Recruiting trials
19
US states with sites
5
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 2Not applicable 1

Drugs and treatments being studied

InterventionTrials
Alisertib1
Bortezomib (B)1
Capecitabine tablets1
Cisplatin (CDDP)1
Endocrine therapy1
Eribulin mesylate injection1
Fulvestrant injection1
Gemcitabine hydrochloride for injection1
Paclitaxel for injection (albumin-bound)1
TQB2930 for injection1
TQB3616 capsule1
Vinorelbine tartrate injection1

Where trials are recruiting (top US states)

StateRecruiting trials
Alabama1
Arizona1
California1
Colorado1
Connecticut1
Florida1
Georgia1
Illinois1
Massachusetts1
Minnesota1
Missouri1
Nevada1

Top cities

Atlanta, Georgia 1Aurora, Colorado 1Beverly Hills, California 1Birmingham, Alabama 1Boston, Massachusetts 1Chapel Hill, North Carolina 1Chicago, Illinois 1Columbia, Missouri 1Columbus, Ohio 1Dallas, Texas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Recurrent Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.

Breast cancer 2239Metastatic breast cancer 131Hormone Receptor Positive HER-2 Negative Breast Cancer 8Breast Carcinoma 74Advanced Malignancies 3

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Recurrent Breast Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.